Publication | Open Access
Orphan Drugs Offer Larger Health Gains but Less Favorable Cost-effectiveness than Non-orphan Drugs
49
Citations
18
References
2020
Year
Drug RepositioningHealth SciencesHealth PolicyHealth EconomicsPharmacologyPharmacoeconomicsLess Favorable Cost-effectivenessPharmacotherapyOrphan DrugMedicineHarm ReductionNon-orphan Drugs
| Year | Citations | |
|---|---|---|
Page 1
Page 1